Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Demogao Pharmaceutical Technology is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Founded in 2011 and headquartered in Beijing, the company provides integrated CRO and CDMO services to the global life sciences industry, with a core focus on complex small molecule synthesis. Their business model encompasses the entire drug development lifecycle, from laboratory-scale custom synthesis and process optimization to industrial-scale production. Demogao's technical expertise supports various therapeutic areas, including oncology, cardiovascular health, and anti-infectives. The company operates advanced R&D facilities and manufacturing sites that adhere to international quality standards to support both domestic and export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Demogao Pharmaceutical Technology.